True Wealth Design’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$211K Buy
4,828
+1,937
+67% +$89.7K 0.05% 121
2026
Q2
$123K Buy
2,891
+1,536
+113% +$83.4K 0.03% 200
2026
Q1
$85K Buy
1,355
+1,164
+609% +$93.1K 0.02% 253
2025
Q4
$18.2K Sell
191
-222
-54% -$21.8K 0.01% 646
2025
Q3
$40.3K Buy
413
+202
+96% +$20.9K 0.01% 379
2025
Q2
$22.6K Buy
211
+39
+23% +$3.95K 0.01% 355
2025
Q1
$17.3K Buy
172
+130
+310% +$13.1K 0.01% 367
2024
Q4
$3.71K Buy
42
+19
+83% +$1.67K ﹤0.01% 595
2024
Q3
$1.93K Hold
23
– – ﹤0.01% 804
2024
Q2
$1.77K Buy
23
+6
+35% +$439 ﹤0.01% 381
2024
Q1
$1.17K Buy
17
+7
+70% +$450 ﹤0.01% 431
2023
Q4
$579 Hold
10
– – ﹤0.01% 441
2023
Q3
$528 Hold
10
– – ﹤0.01% 418
2023
Q2
$541 Hold
10
– – ﹤0.01% 422
2023
Q1
$501 Hold
10
– – ﹤0.01% 523
2022
Q4
$463 Buy
+10
New +$433 ﹤0.01% 474

Other funds holding BSX

True Wealth Design's BSX Position: Q3 2026 in Review

True Wealth Design increased its Boston Scientific (BSX) stake by 67% in Q3 2026, buying an estimated $89.7K and bringing the position to 4,828 shares worth $211K. The position accounts for 0.05% of the portfolio, ranked #121.

True Wealth Design first reported a position in BSX in Q4 2022 and has held it in 16 quarters since. 164 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

  • True Wealth Design held 4,828 shares of Boston Scientific worth $211K as of Q3 2026.
  • True Wealth Design bought 1,937 Boston Scientific shares in Q3 2026, an estimated $89.7K.
  • Boston Scientific made up 0.05% of True Wealth Design's portfolio in Q3 2026, its #121 holding.
  • True Wealth Design first reported a position in Boston Scientific in Q4 2022 and has held it in 16 quarters since.
  • 164 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on True Wealth Design's 13F filing for Q3 2026, filed 13 Oct 2026.